Blisphora By Metagenics Overview & Drug Interactions

Check For Interactions With Blisphora

Supplement: Blisphora by Metagenics

Blisphora Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Blisphora by Metagenics

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 30
UPC/BARCODE 755571936257

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Folate
1665 mcg DFE
Vitamin B9 (Folate) 416%
Vitamin B12
1000 mcg
Vitamin B12 41667%
S-Adenosyl-L-Methionine
400 mg
SAMe --

Other Ingredients:
Microcrystalline Cellulose
Magnesium Stearate
Stearic Acid
Silica
Mannitol
Carboxymethylstarch Sodium Salt
Coating
Forms
  • Methacrylic Acid Copolymer
  • Silica
  • Titanium Dioxide
  • Triethyl Citrate


Label Statments:


Formulation
- Formulated to support a healthy mood and methylation
- This product is non-GMO, gluten-free, and vegetarian.
- This product is non-GMO, gluten-free, and vegetarian.
Formula
- Features SAMe, folate, and vitamin B12
- Blisphora features SAMe (s-adenosyl-L-methionine), a compound native to the body that is a component of many biochemical reactions. This formula combines folate (the next generation of folate with improved bioavailability) and vitamin B12 (as easy-to-absorb methylcobalamin) to support SAMe metabolism, methylation, and healthy neurotransmitter synthesis for a balanced mood. Foil-wrapped, enteric-coated tablets ensure product stability.
General Statements
- Practitioner exclusive
FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Directions: Take one tablet daily 30 minutes before a meal on an empty stomach with water or as directed by your healthcare practitioner.
Precautions
- Warning: Do not use if you are pregnant or nursing. Caution: If you have a history of psychiatric disorders or if you are taking medication, particularly antidepressants such as MAO inhibitors or selective serotonin reuptake inhibitors (SSRIs), consult your healthcare practitioner prior to use.
- Keep out of the reach of children.
- This product is manufactured in a facility that produces products containing wheat, gluten, milk, egg, soy, fish, and crustacean shellfish ingredients.
Storage
- Storage: Keep in a cool, dry place.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Brand IP Statement(s)
- Quatrefolic is a registered trademark of Gnosis S.P.A., U.S. Patent No. 7,947,662

Brand Information

See all products by this brand

Distributed by
Name Metagenics
City Gig Harbor
State WA
ZipCode 98332
Phone Number 800 692 9400
Web Address metagenics.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.